Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights.
Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Agilent Technologies Company is mentioned.
We assess its relevance and importance to carry out an overall sentiment valuation of Agilent Technologies, Inc. (A).
You can view the trend designation for each individual article below.
We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Agilent Technologies stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Agilent Technologies, Inc. (A)
The Nasdaq 100 closed higher by around 0.4% on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.
In Article Trend:Neutral
March 28, 2024 (10:15) / "PR Newswire" (by Research and Markets)
DUBLIN, March 28, 2024 /PRNewswire/ -- The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering.
In Article Trend:Neutral
March 27, 2024 (13:30) / "Benzinga" (by Globe Newswire)
Chicago, March 27, 2024 ( GLOBE NEWSWIRE ) -- The Food Diagnostics Market refers to the industry involved in the development, production, and distribution of diagnostic tools and technologies used in the food industry.
In Article Trend:Bullish
March 26, 2024 (16:00) / "Benzinga" (by Benzinga Insights)
In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In this article, we will conduct an extensive industry comparison, evaluating Agilent Technologies A in relation to its major competitors in ...
In Article Trend:Somewhat-Bullish
March 20, 2024 (19:45) / "Benzinga" (by Benzinga Insights)
Agilent Technologies's A short percent of float has risen 9.82% since its last report. The company recently reported that it has 3.21 million shares sold short, which is 1.23% of all regular shares that are available for trading.
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
In Article Trend:Somewhat-Bullish
March 13, 2024 (16:35) / "Benzinga" (by Piero Cingari)
Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates. Goldman Sachs projects the global obesity market to potentially reach $100 billion by 2030, with a more optimistic outlook suggesting it ...
In Article Trend:Somewhat-Bullish
March 13, 2024 (12:30) / "Benzinga" (by Globe Newswire)
New York, United States, March 13, 2024 ( GLOBE NEWSWIRE ) -- In Vitro toxicology testing is used to determine the toxicity of a substance on non-living cells or tissues. It is a crucial component of preclinical safety evaluation in the pharmaceutical, chemical, and regulatory industries.
In Article Trend:Somewhat-Bullish
March 11, 2024 (09:22) / "Benzinga" (by Globe Newswire)
Agilent Technologies A has outperformed the market over the past 15 years by 3.71% on an annualized basis producing an average annual return of 17.29%. Currently, Agilent Technologies has a market capitalization of $43.76 billion.
In Article Trend:Somewhat-Bullish
March 8, 2024 (08:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
Agilent Technologies ( A ) had its Relative Strength ( RS ) Rating upgraded from 76 to 81 Friday. X This unique rating tracks market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
In Article Trend:Bullish
March 7, 2024 (11:30) / "Benzinga" (by Globe Newswire)
Wilmington, Delaware, United States, March 07, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global laboratory vacuum pumps market is estimated to flourish at a CAGR of 5.1% from 2023 to 2031.
In Article Trend:Somewhat-Bullish
March 7, 2024 (09:43) / "Benzinga" (by Globe Newswire)
Wilmington, Delaware, United States, March 07, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global landscape of the medical membrane market promises to flourish with a CAGR of 9.2% by the end of 2031.
In Article Trend:Somewhat-Bullish
March 7, 2024 (07:31) / "Benzinga" (by Globe Newswire)
Wilmington, Delaware, United States, March 07, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global biomarkers market is estimated to flourish at a CAGR of 10.4% from 2023 to 2031.
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Agilent Technologies ( A ) stock saw a positive improvement to its Relative Strength ( RS ) Rating on Tuesday, rising from 65 to 71. IBD's unique rating tracks market leadership with a 1 ( worst ) to 99 ( best ) score.
In Article Trend:Bullish
March 5, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)
Agilent Technologies ( A ) saw a positive improvement to its Relative Strength ( RS ) Rating on Tuesday, rising from 65 to 71. X IBD's unique rating tracks market leadership with a 1 ( worst ) to 99 ( best ) score.
Agilent Technologies A has outperformed the market over the past 10 years by 2.3% on an annualized basis producing an average annual return of 12.77%. Currently, Agilent Technologies has a market capitalization of $40.28 billion.
In Article Trend:Somewhat-Bullish
February 29, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Chicago, Feb. 29, 2024 ( GLOBE NEWSWIRE ) -- Transfection Technologies market in terms of revenue was estimated to be worth $1.2 billion in 2023 and is poised to reach $1.8 billion by 2028, growing at a CAGR of 9.4% from 2023 to 2028 according to a latest report published by MarketsandMarkets™.
Sentiments turn negative on Wednesday after the mixed performance in the previous session, as the focus shifts to some key Main Street data. Traders may prefer to move to the sidelines to see off some key economic catalysts due for the week.
Agilent (A) delivered earnings and revenue surprises of 6.61% and 5.53%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend:Somewhat-Bullish
February 27, 2024 (10:49) / "Benzinga" (by Shanthi Rexaline)
U.S. stocks are poised for a potential rebound on Tuesday after facing concerns about valuations in the previous session. Early trading shows modest gains in major index futures, indicating continued market momentum.
In Article Trend:Neutral
February 26, 2024 (20:06) / "Zacks Commentary" (by Shaun Pruitt)
With representation from a variety of sectors, several top-rated Zacks stocks look attractive ahead of their quarterly reports on Tuesday, February 27.
Itron (ITRI) delivered earnings and revenue surprises of 64% and 1.12%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
NICE's fourth-quarter 2023 results reflect benefits from robust cloud revenues, driven by increased migration to the cloud and an expanding customer base.
Wilmington, Delaware, United States, Feb. 23, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global HPLC market was projected to attain US$ 4.2 billion in 2022. It is anticipated to garner a 5.3% CAGR from 2023 to 2031 and by 2031, the market is likely to attain US$ 6.6 ...
Beyond analysts' top -and-bottom-line estimates for Agilent (A), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended January 2024.
In Article Trend:Neutral
February 22, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)
On Thursday, Charles River Labs Intl ( CRL ) reached an important technical milestone, seeing its Relative Strength ( RS ) Rating jump into the 80-plus percentile with an improvement to 83, up from 80 the day before.
CoStar Group's (CSGP) fourth-quarter 2023 results reflect solid top-line growth, led by robust performance in key segments and acquisitions like OnTheMarket in the U.K.
Wilmington, Delaware, United States, Feb. 20, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global microarray scanners market is estimated to flourish at a CAGR of 7.5% from 2023 to 2031.
In Article Trend:Somewhat-Bullish
February 19, 2024 (15:15) / "PR Newswire" (by Research and Markets)
Wilmington, Delaware, United States, Feb. 15, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The C-reactive protein testing market was worth US$ 3.1 billion in 2022. A CAGR of 2.9% is projected from 2023 to 2031, and the market will reach more than US$ 4.0 billion in 2031.
Cognex Corporation (CGNX) delivered earnings and revenue surprises of 0% and 4.27%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Wilmington, Delaware, United States, Feb. 14, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The polymerase chain reaction ( PCR ) consumables market was valued at US$ 520.5 million in 2022. The market is expected to reach US$ 754.4 million by the end of 2031, expanding at a CAGR ...
In Article Trend:Somewhat-Bullish
February 13, 2024 (17:00) / "Benzinga" (by Benzinga Insights)
Agilent Technologies A has outperformed the market over the past 10 years by 2.33% on an annualized basis producing an average annual return of 12.73%. Currently, Agilent Technologies has a market capitalization of $38.31 billion.
In Article Trend:Somewhat-Bullish
February 13, 2024 (16:30) / "Benzinga" (by Globe Newswire)
LONDON, Feb. 13, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's small cell lung cancer therapeutics global market report 2024, the small cell lung cancer therapeutics market is poised for remarkable growth.
In Article Trend:Neutral
February 12, 2024 (11:30) / "Benzinga" (by Globe Newswire)
New York, United States, Feb. 12, 2024 ( GLOBE NEWSWIRE ) -- This study examines the effects of uncommon diseases on a significant portion of the global population. There are over 7000 uncommon diseases, and inadequate information is available for many of them, limiting diagnostic and therapeutic ...
In Article Trend:Neutral
February 9, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Chicago, Feb. 09, 2024 ( GLOBE NEWSWIRE ) -- Molecular Cytogenetics market in terms of revenue was estimated to be worth $3.1 billion in 2023 and is poised to reach $4.9 billion by 2028, growing at a CAGR of 9.9% from 2023 to 2028 according to a latest report published by MarketsandMarkets™.
Wilmington, Delaware, United States, Feb. 06, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global forensic technologies market is estimated to flourish at a CAGR of 13.2% from 2021 to 2028.
In Article Trend:Somewhat-Bullish
February 6, 2024 (10:28) / "Benzinga" (by Globe Newswire)
New York, Feb. 06, 2024 ( GLOBE NEWSWIRE ) -- According to Market.us, the Global Oligonucleotide Synthesis market size is forecasted to exceed USD 44.9 Billion by 2033, with a promising CAGR of 17.3% from 2024 to 2033.
In Article Trend:Somewhat-Bullish
February 6, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)
The Relative Strength ( RS ) Rating for Myriad Genetics ( MYGN ) entered a new percentile Tuesday, with an increase from 79 to 88. When looking for the best stocks to buy and watch, keep a close on eye on relative price strength. IBD's unique rating tracks price movement with a 1 ( worst ) ...
In Article Trend:Bullish
February 6, 2024 (08:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
The Relative Strength ( RS ) Rating for Charles River Labs Intl ( CRL ) headed into a new percentile Tuesday, as it got a lift from 68 to 71. X As you try to find the best stocks to buy and watch, keep a close on eye on relative price strength.
In Article Trend:Somewhat-Bullish
February 5, 2024 (17:30) / "Benzinga" (by Globe Newswire)
Wilmington, Delaware, United States, Feb. 05, 2024 ( GLOBE NEWSWIRE ) -- The global gene synthesis market is estimated to flourish at a CAGR of 23.6% from 2023 to 2033. Transparency Market Research projects that the overall sales revenue for gene synthesis is estimated to reach US$ 14.2 billion ...
Futures for the Samp;P 500 and Dow Jones Industrial Average were down 0.2% about 7 a.m. ET, while Nasdaq futures slipped 0.1% in early-morning trading. Benchmark 10-year Treasury yields edged up 7 basis points, while a widely followed gauge of the US dollar's strength climbed 0.4%.
In Article Trend:Neutral
February 5, 2024 (12:51) / "Business Insider" (by George Glover)
Wilmington, Delaware, United States, Feb. 02, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The flow cytometry market accounted for US$ 4.4 billion in 2022. A CAGR of 8.0% is expected from 2023 to 2031, resulting in US$ 8.8 billion by 2031.
In Article Trend:Somewhat-Bullish
February 1, 2024 (18:30) / "Benzinga" (by Benzinga Insights)
Agilent Technologies A has outperformed the market over the past 10 years by 1.62% on an annualized basis producing an average annual return of 12.39%. Currently, Agilent Technologies has a market capitalization of $38.70 billion.
Investors with an interest in Electronics - Testing Equipment stocks have likely encountered both Fortive ( FTV Quick QuoteFTV - ) and Agilent Technologies ( A Quick QuoteA - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
Fortive (FTV) delivered earnings and revenue surprises of 5.38% and 0.99%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend:Somewhat-Bullish
January 30, 2024 (11:30) / "PR Newswire" (by Trimble)
Kara Sprague and Ron Nersesian elected as new independent directors WESTMINSTER, Colo., Jan. 30, 2024 /PRNewswire/ -- Trimble Inc. ( NASDAQ: TRMB ) announced today the appointment of Kara Sprague and Ron Nersesian to its Board of Directors, effective February 5, 2024.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website